Investor Relations

News Release

Printer Friendly Version View printer-friendly version
<< Back
KemPharm, Inc. to Report Third Quarter 2016 Results

Conference Call and Live Audio Webcast Scheduled for November 9th, 2016, 5:00 p.m. ET

CORALVILLE, Iowa, Nov. 01, 2016 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today announced that the Company will host a conference call and live audio webcast on Wednesday, November 9, 2016, at 5:00 p.m. ET, to discuss its corporate and financial results for the third quarter 2016.

Conference Call Information:
Interested participants and investors may access the conference call by dialing either:

  • (866) 395-2480 (U.S.)
  • (678) 509-7538 (international)
  • Conference ID: 11692265

An audio webcast will be accessible via the Investor Relations section of the KemPharm website http://investors.kempharm.com/.  An archive of the webcast will remain available for 90 days beginning at approximately 6:00 p.m. ET, on November 9, 2016.

About KemPharm
KemPharm is a clinical-stage specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs to treat serious medical conditions through its LAT platform technology.  KemPharm utilizes its LAT platform technology to generate improved prodrug versions of FDA-approved drugs in the high need areas of pain, ADHD and other CNS disorders. 

Investor Contacts:        Media Contact:
Jason Rando / Joshua Drumm, Ph.D.
Tiberend Strategic Advisors, Inc.
212-375-2665 / 2664
jrando@tiberend.com
jdrumm@tiberend.com
      Daniel L. Cohen
Executive Vice President, Government and Public Relations
KemPharm, Inc.
202-329-1825
dcohen@kempharm.com
 

Primary Logo

KemPharm